Bridgeway Capital Management’s T2 Biosystems, Inc TTOO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-57
Closed -$32K 1478
2022
Q3
$32K Hold
57
﹤0.01% 1371
2022
Q2
$46K Hold
57
﹤0.01% 1289
2022
Q1
$148K Hold
57
﹤0.01% 1220
2021
Q4
$146K Hold
57
﹤0.01% 1188
2021
Q3
$259K Sell
57
-60
-51% -$302K ﹤0.01% 1177
2021
Q2
$693K Sell
117
-8
-6% -$51.7K 0.01% 979
2021
Q1
$1.01M Buy
125
+70
+127% +$741K 0.02% 861
2020
Q4
$341K Sell
55
-26
-32% -$159K 0.01% 1084
2020
Q3
$550K Hold
81
0.01% 850
2020
Q2
$514K Buy
81
+50
+161% +$212K 0.01% 848
2020
Q1
$100K Hold
31
﹤0.01% 1176
2019
Q4
$181K Buy
31
+1
+3% +$9.45K ﹤0.01% 1206
2019
Q3
$375K Hold
30
0.01% 1044
2019
Q2
$252K Hold
30
﹤0.01% 1139
2019
Q1
$395K Hold
30
﹤0.01% 1090
2018
Q4
$452K Hold
30
0.01% 1028
2018
Q3
$1.12M Hold
30
0.01% 838
2018
Q2
$1.16M Hold
30
0.01% 823
2018
Q1
$974K Hold
30
0.01% 852
2017
Q4
$618K Sell
30
-17
-36% -$351K 0.01% 1027
2017
Q3
$991K Buy
47
+20
+74% +$371K 0.01% 848
2017
Q2
$436K Hold
27
0.01% 1129
2017
Q1
$715K Buy
+27
New +$759K 0.01% 934

Other funds holding TTOO

Bridgeway Capital Management's TTOO Position: Q4 2022 in Review

Bridgeway Capital Management sold out of T2 Biosystems, Inc (TTOO) in Q4 2022, closing a stake of 57 shares — an estimated $32K sold.

Bridgeway Capital Management first reported a position in TTOO in Q1 2017 and held it in 23 quarters. The position peaked at $1.16M in Q2 2018. 20 funds tracked by Wall St. Rank hold TTOO as of Q4 2022.

  • Bridgeway Capital Management reported no remaining T2 Biosystems, Inc position as of Q4 2022 after selling out during the quarter.
  • Bridgeway Capital Management sold 57 T2 Biosystems, Inc shares in Q4 2022, an estimated $32K.
  • Bridgeway Capital Management first reported a position in T2 Biosystems, Inc in Q1 2017 and held it in 23 quarters.
  • Bridgeway Capital Management's T2 Biosystems, Inc position peaked at $1.16M in Q2 2018.
  • 20 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2022.

Based on Bridgeway Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.